We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Mediclinic International Plc | LSE:MDC | London | Ordinary Share | GB00B8HX8Z88 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 501.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMMDC
RNS Number : 0808M
Mediclinic International plc
26 July 2017
Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", the "Company" or the "Group")
26 July 2017
ANNOUNCEMENT OF THE ANNUAL GENERAL MEETING POLL RESULTS
Mediclinic announces that at its Annual General Meeting ("AGM") held on 25 July 2017, all resolutions set out in the notice of the AGM were passed by the requisite majority of votes by shareholders by way of poll. The results of the poll for each resolution were as follows:
Hot Features
Premium
TOTAL % OF VOTES % VOTES % VOTES
SHARES ISSUED FOR AGAINST WITHHELD
VOTED SHARE
CAPITAL
VOTED
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
ORDINARY RESOLUTIONS
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To receive
the Company's
financial statements
and the reports
by the Directors
1. and auditors 643,346,097 87.26% 642,608,938 99.99% 211 0.01% 736,948
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To approve
the Directors'
Remuneration
2. Report 643,346,097 87.26% 618,212,690 96.25% 24,075,900 3.75% 1,057,507
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To approve
the amended
Directors'
Remuneration
3. Policy 643,346,097 87.26% 614,711,926 95.95% 25,915,697 4.05% 2,718,474
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To declare
a final dividend
of 4.70 pence
per ordinary
4. share 643,346,097 87.26% 642,966,257 99.99% 211 0.01% 379,629
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To elect Jurgens
Myburgh as
5. a Director 643,346,097 87.26% 640,899,142 99.68% 2,060,463 0.32% 386,492
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To re-elect
Danie Meintjes
6. as a Director 643,346,097 87.26% 642,864,882 99.99% 94,723 0.01% 386,492
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To re-elect
Dr Edwin Hertzog
7. as a Director 643,346,097 87.26% 625,998,995 97.38% 16,833,567 2.62% 513,535
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To re-elect
Jannie Durand
8. as a Director 643,346,097 87.26% 612,105,167 95.26% 30,444,213 4.74% 796,717
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To re-elect
Alan Grieve
9. as a Director 643,346,097 87.26% 640,694,983 99.93% 445,220 0.07% 2,205,894
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To re-elect
Seamus Keating
10. as a Director 643,346,097 87.26% 641,082,006 99.99% 46,572 0.01% 2,217,519
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To re-elect
Prof Dr Robert
11. Leu as a Director 643,346,097 87.26% 641,083,644 99.99% 44,934 0.01% 2,217,519
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To re-elect
Nandi Mandela
12. as a Director 643,346,097 87.26% 642,901,226 99.99% 49,254 0.01% 395,617
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To re-elect
Trevor Petersen
13. as a Director 643,346,097 87.26% 632,937,299 98.72% 8,191,279 1.28% 2,217,519
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To re-elect
Desmond Smith
14. as a Director 643,346,097 87.26% 639,878,832 99.87% 836,521 0.13% 2,630,744
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To re-appoint
PricewaterhouseCoopers
LLP as auditors
15. of the Company 643,346,097 87.26% 642,446,940 99.99% 3,656 0.01% 895,501
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To authorise
the Audit and
Risk Committee
to determine
the remuneration
16. of the auditors 643,346,097 87.26% 642,417,589 99.98% 120,859 0.02% 807,649
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To authorise
the Directors
to make political
17. donations 643,346,097 87.26% 566,825,468 89.04% 69,771,641 10.96% 6,748,988
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To authorise
the Directors
to allot ordinary
18. shares 643,346,097 87.26% 527,047,324 82.04% 115,391,424 17.96% 907,349
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
SPECIAL RESOLUTIONS
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To authorise
the Directors
to dis-apply
the statutory
pre-emption
19. rights 643,346,097 87.26% 583,771,316 91.13% 56,840,187 8.87% 2,734,594
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To authorise
the Directors
to dis-apply
pre-emption
rights for
purposes of
acquisitions
or capital
20. investments 643,346,097 87.26% 591,889,385 93.19% 43,253,058 6.81% 8,203,654
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To authorise
the amendment
to the Articles
21. of Association 643,346,097 87.26% 641,126,245 99.99% 1,314 0.01% 2,218,538
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
To approve
the reduction
in minimum
notice period
for general
meetings (other
than annual
22. general meetings) 643,346,097 87.26% 617,065,427 96.43% 22,854,064 3.57% 3,426,606
----- ------------------------ ------------ --------- ------------ ------- ------------ ------- ----------
VOTES OF SHAREHOLDERS EXCLUDING THE CONTROLLING SHAREHOLDER ON ELECTION AND RE-ELECTION OF INDEPENT NON-EXECUTIVE DIRECTORS
ORDINARY RESOLUTIONS TOTAL % OF VOTES % VOTES % VOTED
SHARES ISSUED FOR AGAINST WITHHELD
VOTED SHARE
CAPITAL
VOTED
---- --------------------- ------------ --------- ------------ ------- ---------- ------ ----------
To re-elect
Alan Grieve
9. as a Director 571,230,713 77.48% 568,579,599 99.92% 445,220 0.08% 2,205,894
---- --------------------- ------------ --------- ------------ ------- ---------- ------ ----------
To re-elect
Seamus Keating
10. as a Director 571,230,713 77.48% 568,966,622 99.99% 46,572 0.01% 2,217,519
---- --------------------- ------------ --------- ------------ ------- ---------- ------ ----------
To re-elect
Prof Dr Robert
11. Leu as a Director 571,230,713 77.48% 568,968,260 99.99% 44,934 0.01% 2,217,519
---- --------------------- ------------ --------- ------------ ------- ---------- ------ ----------
To re-elect
Nandi Mandela
12. as a Director 571,230,713 77.48% 570,785,842 99.99% 49,254 0.01% 395,617
---- --------------------- ------------ --------- ------------ ------- ---------- ------ ----------
To re-elect
Trevor Petersen
13. as a Director 571,230,713 77.48% 560,821,915 98.56% 8,191,279 1.44% 2,217,519
---- --------------------- ------------ --------- ------------ ------- ---------- ------ ----------
To re-elect
Desmond Smith
14. as a Director 571,230,713 77.48% 567,763,448 99.85% 836,521 0.15% 2,630,744
---- --------------------- ------------ --------- ------------ ------- ---------- ------ ----------
Notes:
1. Any proxy appointments giving discretion
to the Chairman of the Meeting have been
included in the "For" total.
2. A vote "Withheld" is not a vote in law and
is not counted in the calculation of the
votes "For" or "Against" a resolution.
3. The Company's total ordinary shares in issue
(total voting rights) as at 25 July 2017
was 737 243 810 ordinary shares of 10 pence
each. Ordinary shareholders are entitled
to one vote per ordinary share held.
4. As the Company has a controlling shareholder,
Remgro Limited, as defined in the Financial
Conduct Authority's Listing Rules, each
resolution to elect an independent non-executive
director (resolutions 9 to 14) have under
Listing Rule 9.2.2E been approved by a majority
of the votes cast by:
(a) the shareholders of the Company as a
whole; and
(b) the independent shareholders of the
Company, that is, all the shareholders entitled
to vote on each resolution, excluding the
controlling shareholder.
In accordance with paragraph 9.6.2 of the Listing Rules, a copy of the resolutions passed at the meeting has been submitted to the National Storage Mechanism and will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM.
The complete poll results and details of proxy votes lodged before the AGM will be available shortly on the Company's website at www.mediclinic.com.
About Mediclinic International plc
Mediclinic is an international private healthcare group with operating platforms in Southern Africa (South Africa and Namibia), Switzerland and the United Arab Emirates. Its core purpose is to enhance the quality of life of patients by providing acute care, specialist-orientated, multi-disciplinary healthcare services. Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a LSE listed and UK-based private healthcare group.
Mediclinic comprises 74 hospitals and 37 clinics. Mediclinic Southern Africa operates 49 hospitals and 2 day clinics throughout South Africa and 3 hospitals in Namibia with more than 8 000 inpatient beds in total; Hirslanden operates 16 private acute care facilities and 4 clinics in Switzerland with more than 1 600 inpatient beds; and Mediclinic Middle East operates 6 hospitals and 31 clinics with more than 700 inpatient beds in the United Arab Emirates.
During February 2016, the combination of the Company (previously named Al Noor Hospitals Group plc), with operations mainly in Abu Dhabi in the United Arab Emirates, and Mediclinic International Limited was completed. Mediclinic International Limited was a South African based international private healthcare group founded in 1983 and listed on the JSE, the South African stock exchange, since 1986, with operations in South Africa, Namibia, Switzerland and the United Arab Emirates (mainly in Dubai). The combination resulted in the renaming of the enlarged group to Mediclinic International plc.
Mediclinic has a primary listing on the Main Market of the LSE, with secondary listings on the JSE in South Africa and the NSX in Namibia.
For further information, please contact:
Capita Company Secretarial Services Limited
Victoria Dalby
+44 (0)207 954 9600
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard/Debbie Scott (UK)
+44 (0)20 3727 1000
Frank Ford (South Africa)
+27 (0)21 487 9000
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGSEEFAIFWSEFW
(END) Dow Jones Newswires
July 26, 2017 02:30 ET (06:30 GMT)
1 Year Mediclinic Chart |
1 Month Mediclinic Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
